| Literature DB >> 28036090 |
Patrícia A B Ramos1,2, Ângela R Guerra3,4, Olinda Guerreiro5,6, Sónia A O Santos7, Helena Oliveira8, Carmen S R Freire9, Armando J D Silvestre10, Maria F Duarte11.
Abstract
Besides being traditionally used to relieve hepatobiliary disorders, Cynara cardunculus L. has evidenced anticancer potential on triple-negative breast cancer (TNBC). This study highlights the antiproliferative effects of lipophilic extracts from C. cardunculus L. var. altilis (DC) leaves and florets, and of their major compounds, namely cynaropicrin and taraxasteryl acetate, against MDA-MB-231 cells. Our results demonstrated that MDA-MB-231 cells were much less resistant to leaves extract (IC50 10.39 µg/mL) than to florets extract (IC50 315.22 µg/mL), during 48 h. Moreover, leaves extract and cynaropicrin (IC50 6.19 µg/mL) suppressed MDA-MB-231 cells colonies formation, via an anchorage-independent growth assay. Leaves extract and cynaropicrin were also assessed regarding their regulation on caspase-3 activity, by using a spectrophotometric assay, and expression levels of G2/mitosis checkpoint and Akt signaling pathway proteins, by Western blotting. Leaves extract increased caspase-3 activity, while cynaropicrin did not affect it. Additionally, they caused p21Waf1/Cip1 upregulation, as well as cyclin B1 and phospho(Tyr15)-CDK1 accumulation, which may be related to G2 cell cycle arrest. They also downregulated phospho(Ser473)-Akt, without changing total Akt1 level. Cynaropicrin probably contributed to leaves extract antiproliferative action. These promising insights suggest that cultivated cardoon leaves lipophilic extract and cynaropicrin may be considered toward a natural-based therapeutic approach on TNBC.Entities:
Keywords: Cynara cardunculus L. var. altilis (DC); cynaropicrin; lipophilic extracts; p21Waf1/Cip1 upregulation; phospho(Ser473)-Akt downregulation; phospho(Tyr15)-CDK1 protein accumulation; taraxasteryl acetate; triple-negative breast cancer MDA-MB-231 cell line
Mesh:
Substances:
Year: 2016 PMID: 28036090 PMCID: PMC5297698 DOI: 10.3390/ijms18010063
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Structures of major lipophilic compounds identified in C. cardunculus L. var. altilis (DC) leaves and florets: (a) Cynaropicrin; (b) Taraxasteryl acetate.
IC50 values of cultivated cardoon lipophilic extracts and cynaropicrin on the 48 h cellular viability of MDA-MB-231 cells, by using the MTT assay.
| Cultivated Cardoon Extract/Pure Compound | IC50 for Antiproliferative Activity (µg/mL) 1 |
|---|---|
| Leaves lipophilic extract | 10.39 ± 0.41 b |
| Florets lipophilic extract | 315.22 ± 67.88 a |
| Cynaropicrin | 6.19 ± 0.57 b |
1 Each value is expressed as mean ± standard deviation. Three independent experiments were carried out. Means marked with different letters are statistically different (p < 0.05).
Figure 2Effect of 10.39 µg/mL cultivated cardoon leaves lipophilic extract and 6.19 µg/mL cynaropicrin, against MDA-MB-231 cells colonies formation, via an anchorage-independent growth assay, after 14 days. DMSO (0.09% (v/v)) was used as solvent control. (A) Representative photographs of colonies (40× magnification); (B) Number of colonies (n). Each column and bar represents the mean and the standard deviation, respectively. Triplicates were carried out. Columns with different letters are statistically different (p < 0.05).
Figure 3Caspase-3 activity assessment in MDA-MB-231 cells, after 48 h treatments with 10.39 µg/mL cultivated cardoon leaves lipophilic extract and 6.19 µg/mL cynaropicrin. DMSO (0.09% (v/v)) was used as solvent control. Each column and bar represents the mean and the standard deviation, respectively. Three independent experiments were carried out. Columns with different letters are statistically different (p < 0.05).
Cell cycle phases distribution of MDA-MB-231 cells, after 48 h treatments with cultivated cardoon leaves lipophilic extract (10.39 µg/mL) and cynaropicrin (6.19 µg/mL). Solvent control cells received DMSO (0.09% (v/v)).
| Group | MDA-MB-231 Cells (%) 1 | ||
|---|---|---|---|
| G0/G1 | S | G2 | |
| DMSO | 42.5 ± 2.8 a | 45.0 ± 2.2 a | 12.6 ± 3.0 c |
| 10.39 µg/mL leaves lipophilic extract | 15.8 ± 3.1 b | 24.8 ± 2.1 b | 59.5 ± 1.1 a |
| 6.19 µg/mL cynaropicrin | 41.2 ± 3.8 a | 21.0 ± 3.7 b | 37.8 ± 3.1 b |
1 Each value is expressed as mean ± standard deviation. Four replicates were carried out. Means marked with different letters within the same column are statistically different (p < 0.05).
Figure 4Western blot analysis of cyclin B1, p-Tyr15-CDK1 and p21 in MDA-MB-231 cells, after 48 h treatments with 10.39 μg/mL cultivated cardoon leaves lipophilic extract and 6.19 µg/mL cynaropicrin. DMSO (0.09% (v/v)) was used as solvent control. (A) Representative image of immunoblots; (B) Relative expression determined by analysis of band integrated density and normalization to β-actin. Each column and bar respectively represents the mean and the standard deviation of three independent experiments. Columns of each protein with different letters are statistically different (p < 0.05).
Figure 5Western blot analysis of Akt1 and p-Ser473-Akt in MDA-MB-231 cells, after 48 h treatments with 10.39 μg/mL cultivated cardoon leaves lipophilic extract and 6.19 µg/mL cynaropicrin. DMSO (0.09% (v/v)) was used as solvent control. (A) Representative image of immunoblots; (B) Relative expression determined by analysis of band integrated density and normalization to β-actin. Each column and bar respectively represents the mean and the standard deviation of three independent experiments. Columns of each protein with different letters are statistically different (p < 0.05).